Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
Olsson-Strömberg U, Simonsson B, Ahlgren T, Björkholm M, Carlsson K, Gahrton G, Hast R, Löfvenberg E, Linder O, Ljungman P, Malm C, Paul C, Rödjer S, Turesson I, Udén AM, Wahlin A, Killander A, Wadman B, Westin J, Vikrot O, Zettervall O, Oberg G; Swedish CML Study Group.
Olsson-Strömberg U, et al. Among authors: vikrot o.
Hematol J. 2004;5(6):462-6. doi: 10.1038/sj.thj.6200552.
Hematol J. 2004.
PMID: 15570285
Clinical Trial.